Table 2Bariatric outcomes by followup time

StudySurgery0-3 mths4-6 mths7-9 mths10-12 mths13-24 mths>24 mths
Cohen, 200626RYGB§
Lee, 200827RYGB† § #
DeMaria, 201028RYGB
Shah, 201029RYGB§ #§ #† § #
Boza, 201130RYGB#
de Sa, 201131RYGB† § #
Frenken, 201132RYGB† #
Huang, 201133RYGB† § #† § #
Lee, 201134RYGB† #† #† #
Lee,201135RYGB† § #† § #† § #† § #
Ramos, 201136RYGB#
Schauer, 201237RYGB† § #† § #† § #† § #
Serrot,2011a38RYGB† #
Angrisani, 200439LABG
O'Brien, 200640LABG† §
Parikh, 200641LABG
Dixon, 200842LABG† #§
Sultan, 200943LABG
Choi, 2010b44LABG
DeMaria, 201028LABG
Lee, 201134Sleeve† #† #† #
Lembach,2011, T2DM45Sleeve† § #
Lembach,2011,IRc45Sleeve† §
Schauer, 201237Sleeve† § #† § #† § #† § #
Noya, 199846BPD
Scopinaro, 200747BPD† §† §
Chiellini, 200948BPD† #† #
Frenken, 2011d32BPD† #
Scopinaro, 2011, OBe49BPD† § #† § #† § #† § #† § #
Scopinaro, 2011, OWf49BPD† § #† § #† § #† § #† § #

BMI = body mass index;BPD= biliopancreatic diversion; BPD/DS = biliopancreatic diversion with duodenal switch; IR = insulin resistant patients; LABG = laparoscopic adjustable gastric banding; mths = months; OB = obese; OW = overweight; RYGB = Roux-en-Y gastric bypass; Sleeve = sleeve gastrectomy; T2DM = type 2 diabetes mellitus

BMI.

#

HbA1c.

§
a

Only reported Median, used in outcome table.

b

Only usable outcome is % diabetes remission: defined as “% improved/resolved” not otherwise specified.

c

IR=insulin resistant patients.

d

BPD-DS & BPD treated as 1 group.

e

Obese (BMI 30-35).

f

Overweight (BMI 25-30).

From: Results

Cover of Bariatric Surgery and Nonsurgical Therapy in Adults With Metabolic Conditions and a Body Mass Index of 30.0 to 34.9 kg/m2
Bariatric Surgery and Nonsurgical Therapy in Adults With Metabolic Conditions and a Body Mass Index of 30.0 to 34.9 kg/m2 [Internet].
Comparative Effectiveness Reviews, No. 82.
Maglione MA, Gibbons MM, Livhits M, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.